In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Hungarian Society of Cardiology

The Hungarian Society of Cardiology is a member of the European Society of Cardiology

Hungary, HU


 

As a member of the Hungarian Society of Cardiology, you are automatically a member of the European Society of Cardiology and the ESC Community.

Website

Board 2022-2024

President: Dr David Becker, FESC

Honorary Life President: Prof. Gyula Papp, FESC

Honorary President: Prof. Bela Merkely, FESC

President Elect: Prof. Laszlo Alajos Geller, FESC

Past President: Prof. Zoltán Csanádi, FESC

Secretary General: Prof. Zoltán Járai

Vice President: Prof. Zoltán Papp, FESC

Vice President: Ass. Prof. Tamas Habon, FESC

Key information

Number of Members: 4710

Year of Foundation: 1957

ESC Member since: 1972

Journals

Cardiologia Hungarica is the official journal of the Scientific Committee of the Hungarian Society of Cardiology. The first publication was in 1969. Language: Hungarian - four issues per year. An English edition is available simultaneously. Unlimited online full text access and abstracts are available for members on the web. In addition, thematical supplements are issued - 3 to 6 times per year.
Editor in chief: Kiss Róbert Gábor 

Contact the editorial secretariat for more information.

Latest News

The Hungarian Society of Cardiology shares its initiative on improving public education about cardiovascular disease.  Read More

ESC Clinical Practice Guidelines endorsed by your National Society

Date

Title

Topic(s)

Upcoming events

  • Friday 30 August - Monday 02 September 2024 (4 Days)
    30/08/2024 00:00 02/09/2024 00:00 Europe/Paris ESC Congress 2024

    European Society of Cardiology congress@escardio.org true DD/MM/YYYY
    European Society of Cardiology
    London - United Kingdom of Great Britain and Northern Ireland

  • Thursday 07 - Saturday 09 November 2024 (3 Days)
    07/11/2024 13:00 09/11/2024 13:00 Europe/Paris EuroCVP

    Every year the Working Group on Cardiovascular Pharmacotherapy organises EuroCVP Meeting to gather pharmacologists, pharmacists, research nurses and personnel, as well as general cardiologists with an interest in cardiovascular pharmacotherapy, pharmacology and heart failure.

    All cardiologists are concerned by pharmacology and drugs therapy, thus, they should all participate and contribute to EuroCVP.

    During the meeting, focus is made on key treatment breakthroughs, clinical applicability and significance of new drugs and new data. Since 2015, a Clinical Trials Workshop is held in conjunction to the main conference to give a focused view of the clinical trial arena, including trial methodology, trial challenges, trial interpretation and analysis, regulatory issues and good clinical practice.

    London - United Kingdom of Great Britain and Northern Ireland ESC Working Group on Cardiovascular Pharmacotherapy contact@escardio.org DD/MM/YYYY
    ESC Working Group on Cardiovascular Pharmacotherapy
    Budapest - Hungary

    Every year the Working Group on Cardiovascular Pharmacotherapy organises EuroCVP Meeting to gather pharmacologists, pharmacists, research nurses and personnel, as well as general cardiologists with an interest in cardiovascular pharmacotherapy, pharmacology and heart failure.

    All cardiologists are concerned by pharmacology and drugs therapy, thus, they should all participate and contribute to EuroCVP.

    During the meeting, focus is made on key treatment breakthroughs, clinical applicability and significance of new drugs and new data. Since 2015, a Clinical Trials Workshop is held in conjunction to the main conference to give a focused view of the clinical trial arena, including trial methodology, trial challenges, trial interpretation and analysis, regulatory issues and good clinical practice.